SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Trousse D, Barlesi F, Loundou A et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg. 2007;133:11931200.
  • 2
    Aziz TM, Saad RA, Glasser J, et al. The management of second primary lung cancers. A single centre experience in 15 years. Eur J Cardiothorac Surg. 2002;21:527533.
  • 3
    Rosengart TK, Martini N, Ghosn P, et al. Multiple primary lung carcinomas: prognosis and treatment. Ann Thorac Surg. 1991;52:773778.
  • 4
    Rice D, Kim HW, Sabichi A, et al. The risk of second primary tumors after resection of stage I non-small-cell lung cancer. Ann Thorac Surg. 2003;76:10011007.
  • 5
    Bhaskarla A, Tang PC, Mashtare T, et al. Analysis of second primary lung cancers in the SEER database. J Surg Res. 2010;162:16.
  • 6
    Shen KR, Meyers BF, Larner JM, et al. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:290S305S.
  • 7
    Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303:10701076.
  • 8
    Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009;27:32903296.
  • 9
    Chang JY, Liu H, Balter P, et al. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer [serial online]. Radiat Oncol. 2012;7:152.
  • 10
    Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer. 2004;101:16231631.
  • 11
    Creach KM, Bradley JD, Mahasittiwat P, et al. Stereotactic body radiation therapy in the treatment of multiple primary lung cancers. Radiother Oncol. 2012;104:1922.
  • 12
    Matthiesen C, Thompson JS, De La Fuente Herman T, et al. Use of stereotactic body radiation therapy for medically inoperable multiple primary lung cancer. J Med Imaging Radiat Oncol. 2012;56:561566.
  • 13
    Sinha B, McGarry RC. Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience. Int J Radiat Oncol Biol Phys. 2006;66:11201124.
  • 14
    Martini N, Melamed M. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606612.
  • 15
    Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;72:967971.
  • 16
    Kelly P, Balter PA, Rebueno N, et al. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys. 2010;78:13871393.
  • 17
    Liu H, Zhang X, Vinogradskiy YY, et al. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Int J Radiat Oncol Biol Phys. 2012;84:10171023.
  • 18
    Chang JY, Komaki R, Lu C, et al Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. 2011;117:47074713.
  • 19
    Zhang X, Liu H, Balter P, et al. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;85:15581565.
  • 20
    Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2:706714.
  • 21
    Watanabe Y, Shimizu J, Oda M, et al. Second surgical intervention for recurrent and second primary bronchogenic carcinoma. Scand J Thorac Cardiovasc Surg. 1992;26:7378.
  • 22
    Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2011;81:13521358.
  • 23
    Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I nonsmall-cell lung cancer. J Clin Oncol. 2010;28:928935.
  • 24
    Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage I nonsmall cell lung cancer. J Thorac Cardiovasc Surg. 2010;140:377386.
  • 25
    Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012;84:10601070.
  • 26
    Ferguson MK. Synchronous primary lung cancers. Chest. 1993;103:398S400S.
  • 27
    Deschamps C, Pairolero PC, Trastek VF, et al. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg. 1990;99:769777.
  • 28
    van Bodegom PC, Wagenaar SS, Corrin B, et al. Second primary lung cancer: importance of long term follow up. Thorax. 1989;44:788793.
  • 29
    Bongers EM, Haasbeek CJ, Lagerwaard FJ, et al. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early stage lung cancer. J Thorac Oncol. 2011;6:20522057.
  • 30
    Welsh J, Thomas J, Shah D, et al. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2011;81:9196.
  • 31
    Creach KM, El Naqa I, Bradley JD, et al. Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy. Radiother Oncol. 2012;104:2327.